ZINERYT Pdr+Solv for Cut Soln Ірландія - англійська - HPRA (Health Products Regulatory Authority)

zineryt pdr+solv for cut soln

astellas pharma co. ltd - erythromycin, zinc acetate - pdr+solv for cut soln - 40 mg/ml,1 micromol - antiinfectives for treatment of acne

DIFENE 50 Milligram Capsules Gastro-Resistant Ірландія - англійська - HPRA (Health Products Regulatory Authority)

difene 50 milligram capsules gastro-resistant

astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 50 milligram - acetic acid derivatives and related substances

DIFENE 25 Milligram Capsules Gastro-Resistant Ірландія - англійська - HPRA (Health Products Regulatory Authority)

difene 25 milligram capsules gastro-resistant

astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 25 milligram - acetic acid derivatives and related substances

DIFENE 100 Milligram Capsules Modified Release Ірландія - англійська - HPRA (Health Products Regulatory Authority)

difene 100 milligram capsules modified release

astellas pharma co. ltd - diclofenac sodium - capsules modified release - 100 milligram - acetic acid derivatives and related substances

DIFENE DUAL RELEASE 75 Milligram Capsules Modified Release Ірландія - англійська - HPRA (Health Products Regulatory Authority)

difene dual release 75 milligram capsules modified release

astellas pharma co. ltd - diclofenac sodium - capsules modified release - 75 milligram - acetic acid derivatives and related substances

DIFENE AMPOULES 75/3 Mg/Ml Solution injection or concentrate for solution infusion Ірландія - англійська - HPRA (Health Products Regulatory Authority)

difene ampoules 75/3 mg/ml solution injection or concentrate for solution infusion

astellas pharma co. ltd - diclofenac sodium - solution injection or concentrate for solution infusion - 75/3 mg/ml

PROTOPIC- tacrolimus ointment США - англійська - NLM (National Library of Medicine)

protopic- tacrolimus ointment

astellas pharma us inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 0.3 mg in 1 g - protopic ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy  for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic (tacrolimus) ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.